
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.93 | 2.05 | 0.12 |
Stocks | 96.15 | 96.15 | 0.00 |
Other | 1.92 | 1.92 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.00 | 19.58 |
Price to Book | 4.95 | 4.48 |
Price to Sales | 7.16 | 2.54 |
Price to Cash Flow | 18.06 | 17.37 |
Dividend Yield | 1.24 | 1.09 |
5 Years Earnings Growth | 5.62 | 12.04 |
Number of long holdings: 87
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AbbVie | US00287Y1091 | 23.22 | 179.84 | +2.37% | |
Regeneron Pharma | US75886F1075 | 6.90 | 576.72 | +3.58% | |
Amgen | US0311621009 | 6.50 | 291.09 | +3.86% | |
Alnylam | US02043Q1076 | 5.57 | 243.27 | +8.45% | |
Vertex | US92532F1003 | 5.07 | 482.30 | +2.10% | |
argenx ADR | US04016X1019 | 4.88 | 564.13 | +2.77% | |
Ascendis Pharma AS | US04351P1012 | 3.70 | 137.84 | +0.31% | |
Vaxcyte | US92243G1085 | 2.18 | 30.80 | +1.99% | |
Viridian Therapeutics | US92790C1045 | 1.97 | 11.79 | +6.99% | |
Xenon Pharmaceuticals | CA98420N1050 | 1.85 | 31.59 | +11.90% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity 500 Index Institutional Pr | 597.55B | 1.44 | 12.54 | 12.97 | ||
Fidelity Contrafund | 133.27B | 3.52 | 17.24 | 15.17 | ||
Fidelity Total Market Index Instl b | 100.03B | 1.12 | 11.54 | 12.30 | ||
Fidelity Blue Chip Growth | 54.94B | -2.84 | 15.11 | 17.11 | ||
Fidelity Growth Company | 51.83B | -3.07 | 14.73 | 17.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review